Here we explored the effects of skeletal muscle Ctsb expression in an AD mouse model, expressing chimeric mouse/human Swedish amyloid precursor protein (APP) and presenilin delta 9 mutations (APP/PS1), that cause neuropathological changes such as amyloid plaques, gliosis, and cognitive deficits (Jankowsky et al. 2004). Here, APP is linked to Alzheimer disease.